Prenatal exposure to topiramate, valproate, and certain duotherapies is associated with increased risks for autism spectrum disorder (ASD) and intellectual disability (ID), according to a study published online May 31 in ...
May 31, 2022
0
1
An important link has been found between the intellectual disability experienced by children with the rare disease Joubert Syndrome (JS) and defects in the hippocampus. The hippocampus is the part of the brain associated ...
May 10, 2022
0
48
As reported in 2021, autistic adults, adults with intellectual disability and adults with mental health diagnoses have multiple risk factors for COVID-19 infection, and more severe disease if contracted. Public health messaging ...
May 3, 2022
0
14
People with intellectual disability only have their disability noted by hospital staff in one in every five hospital admissions, our new study shows.
May 3, 2022
0
4
Recently released data from the Centers for Disease Control show childhood autism rates are at their highest level since the CDC began tracking data in 2000. About 2.3% of U.S. children, or one in 44, were diagnosed with ...
Apr 29, 2022
0
24
Australian researchers have discovered a new neurodevelopmental disorder after uncovering its link to a tumor suppressor gene.
Apr 7, 2022
0
56
After following a group of patients with a specific gene mutation for many years, a team of UC Davis MIND Institute scientists has provided important insights into how fragile X-associated tremor/ataxia syndrome (FXTAS) first ...
Mar 31, 2022
0
6
In an analysis of data from national Swedish registries for extremely preterm babies (born before 24 weeks) from 2007–2018, most had neurodevelopmental disorders and/or other diagnoses during childhood and were referred ...
Mar 23, 2022
0
0
The early COVID-19 pandemic brought overall declines in children's mental health–related emergency department visits, according to a study in Psychiatric Research and Clinical Practice that analyzed electronic health records ...
Feb 24, 2022
0
3
Science is one step closer to developing targeted drug therapies that may reduce seizures, sleep disorders, and related symptoms common in people with intellectual disabilities.
Feb 22, 2022
0
519
